Medical Direction & Clinical Standards All advanced aesthetic treatments at Bare Necessities are performed by our licensed nursing and clinical team under the medical direction and protocol oversight of our local Medical Director, Dr
What the GLP-1 Conversation Is Getting Wrong Here is what gets left out: eating disorders are common in the very population most likely to be prescribed GLP-1 medications
The six-month bundle drops the rate to $247/mo, and the 12-month bundle drops it to $197/mo
Remarkably, semaglutide has demonstrated considerable weight loss outcomes, with numerous patients attaining up to 20% reduction in weight
Bottom line Wegovy (semaglutide) is a GLP-1 medication that is FDA-approved for individuals living with obesity or overweight
Oral semaglutide has been studied in PIONEER 6 (designed as a non-inferiority trials), with a mean follow-up of 1.3 years and positive results for the primary endpoint: the MACE rate was reduced by 21% but did not achieve statistically significant differences
.png)
